News | March 09, 2023
Lonza upgrades powder characterization capabilities at Tampa
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability
The investment enhances Lonza’s capabilities and flexibility to support both clinical and commercial supply and will play a key role in meeting the growing market demand for bioconjugates
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
Sacu V is priced at Rs. 19 per tablet for a dose of 50 mg (sacubitril 24 mg + valsartan 26 mg)
New facility is based at Lonza’s Bend, Oregon (US) site, a Center of Excellence for bioavailability enhancement
Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules
The unit will have installed manufacturing capacity of over 15 million vials annually that includes lyophilized vials, all in the anti-cancer segment
BDRs journey for the treatment of Prostate Cancer started with Abiratarone Acetate, then Leuprolide Acetate followed by Enzalutamide and, then Degarelix and Triptorelin.
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Subscribe To Our Newsletter & Stay Updated
